This startup wants to prove gene-editing embryos is safe for making healthy babies
Origin Genomics aims to prove that the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks. (Image credit: Mackenzie Calle for NPR)
ImpactNotable 33/100
Why it mattersRule-based estimate: no strong signals; trust 8/10.
RegionsUnited States
Published4 h ago (Tue, 29 Sep 2026 17:00:08 GMT)
RetrievedTue, 29 Sep 2026 20:00:51 GMT via rss
ClassifiedTue, 29 Sep 2026 20:03:42 GMT by heuristic
AuthorRob Stein